440 Investment Group’s Allergan plc AGN Stock Holding History

440 Investment Group’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,100	Closed	-$267K	–	102
2017 Q2	$267K	Buy	+1,100	New	+$258K	0.21%	73

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

440 Investment Group's AGN Position: Q3 2017 in Review

440 Investment Group sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,100 shares — an estimated $267K sold.

440 Investment Group first reported a position in AGN in Q2 2017 and held it in 1 quarter. The position peaked at $267K in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

440 Investment Group reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
440 Investment Group sold 1,100 Allergan plc shares in Q3 2017, an estimated $267K.
440 Investment Group first reported a position in Allergan plc in Q2 2017 and held it in 1 quarter.
440 Investment Group's Allergan plc position peaked at $267K in Q2 2017.
1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on 440 Investment Group's 13F filing for Q3 2017, filed 16 Oct 2017.